Page last updated: 2024-09-04

vatalanib and jnj-7706621

vatalanib has been researched along with jnj-7706621 in 4 studies

Compound Research Comparison

Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010)
(vatalanib)
Studies
(jnj-7706621)
Trials
(jnj-7706621)
Recent Studies (post-2010) (jnj-7706621)
276429840032

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)jnj-7706621 (IC50)
[tau protein] kinase Oryctolagus cuniculus (rabbit)0.0849
Vascular endothelial growth factor receptor 2Rattus norvegicus (Norway rat)0.0849
Aurora kinase AHomo sapiens (human)0.011
Tyrosine-protein kinase JAK2Homo sapiens (human)1.4805
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.0062
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)0.0849
Epidermal growth factor receptorHomo sapiens (human)0.0849
Insulin receptorHomo sapiens (human)0.0849
Cyclin-dependent kinase 1Homo sapiens (human)0.0537
Platelet-derived growth factor receptor betaHomo sapiens (human)0.0849
Calcium/calmodulin-dependent protein kinase type II subunit alphaRattus norvegicus (Norway rat)0.0849
Cyclin-dependent kinase 4Homo sapiens (human)0.11
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.0652
Cyclin-A2Homo sapiens (human)0.0731
Fibroblast growth factor receptor 2Homo sapiens (human)0.1042
G1/S-specific cyclin-D1Homo sapiens (human)0.11
Cyclin-dependent kinase 2Homo sapiens (human)0.0575
G1/S-specific cyclin-D1Mus musculus (house mouse)0.0849
Cyclin-dependent kinase 4Mus musculus (house mouse)0.0849
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.13
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.041
Glycogen synthase kinase-3 betaHomo sapiens (human)0.041
Mitogen-activated protein kinase 1Rattus norvegicus (Norway rat)0.0849
Cyclin-A1Homo sapiens (human)0.002
Disintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)0.0062
Cyclin-dependent kinase 3Homo sapiens (human)0.058
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.0126
Casein kinase I isoform deltaRattus norvegicus (Norway rat)0.0849
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.0062
Aurora kinase BHomo sapiens (human)0.0095

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atteridge, CE; Campbell, BT; Chan, KW; Ciceri, P; Davis, MI; Edeen, PT; Faraoni, R; Floyd, M; Gallant, P; Herrgard, S; Hunt, JP; Karaman, MW; Lockhart, DJ; Milanov, ZV; Morrison, MJ; Pallares, G; Patel, HK; Pritchard, S; Treiber, DK; Wodicka, LM; Zarrinkar, PP1
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Russu, WA; Shallal, HM1
Cahya, S; Cummins, DJ; Gao, C; Iversen, PW; Nicolaou, CA; Vieth, M; Wang, J; Watson, IA1

Other Studies

4 other study(ies) available for vatalanib and jnj-7706621

ArticleYear
A quantitative analysis of kinase inhibitor selectivity.
    Nature biotechnology, 2008, Volume: 26, Issue:1

    Topics: Binding Sites; Enzyme Activation; Humans; Phosphotransferases; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Proteome; Quantitative Structure-Activity Relationship

2008
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:6

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship

2011
Selectivity data: assessment, predictions, concordance, and implications.
    Journal of medicinal chemistry, 2013, Sep-12, Volume: 56, Issue:17

    Topics: Computer Simulation; Drug Discovery

2013